Biomarin Pharmaceutical Inc

Connor, Clark & Lunn Investment Management Ltd. BMRN

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

390,637

Value ($000)

21,157

Weight

0.1%

2019 Q4 - 2025 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	21,157	0.1%	390,637	9/30/2025
2025 Q2	8/7/2025	22,183	0.1%	403,547	6/30/2025
2025 Q1	5/12/2025	36,854	0.2%	521,349	3/31/2025
2024 Q4	2/10/2025	23,432	0.1%	356,496	12/31/2024
2024 Q3	11/8/2024	8,172	0.0%	116,257	9/30/2024
2023 Q3	11/13/2023	468	0.0%	5,292	9/30/2023
2023 Q2	8/10/2023	1,244	0.0%	14,352	6/30/2023
2023 Q1	5/10/2023	22,411	0.1%	230,466	3/31/2023
2022 Q4	2/10/2023	32,899	0.2%	317,896	12/31/2022
2022 Q3	11/10/2022	17,071	0.1%	201,385	9/30/2022
2022 Q2	8/5/2022	20,486	0.1%	247,201	6/30/2022
2022 Q1	5/12/2022	12,020	0.1%	155,903	3/31/2022
2021 Q4	2/10/2022	1,175	0.0%	13,297	12/31/2021
2021 Q3	11/12/2021	5,513	0.0%	71,331	9/30/2021
2021 Q2	8/12/2021	1,728	0.0%	20,708	6/30/2021
2021 Q1	5/13/2021	589	0.0%	7,798	3/31/2021
2020 Q4	2/16/2021	2,227	0.0%	25,392	12/31/2020
2020 Q3	11/12/2020	693	0.0%	9,108	9/30/2020
2020 Q2	8/13/2020	952	0.0%	7,721	6/30/2020
2019 Q4	2/12/2020	744	0.0%	8,800	12/31/2019